Vitamin K

What is Vitamin K?

Vitamin K is a fat-soluble essential nutrient best known for its role in normal blood clotting and, increasingly, for its contributions to bone and cardiovascular health. It is not a single molecule but a family of related compounds that share a quinone ring structure and participate in the “vitamin K cycle,” a biochemical pathway that enables the activation (carboxylation) of several proteins. The two major forms are phylloquinone (vitamin K1) , found primarily in green leafy vegetables and plant oils, and menaquinones (vitamin K2) , a group of compounds produced by certain bacteria and present in fermented foods and some animal products. Among K2 forms, MK-4 and MK-7 are the most discussed in nutrition and supplementation.

In the body, vitamin K serves as a cofactor for enzymes that activate “Gla-proteins” (gamma-carboxyglutamate–containing proteins). These include clotting factors (such as prothrombin) that help stop bleeding, osteocalcin involved in bone mineralization, and matrix Gla protein (MGP) , which helps regulate calcium deposition in blood vessels and soft tissues. Because humans cannot synthesize enough vitamin K de novo, it is considered essential and must come primarily from foods and, in some cases, supplements.

Vitamin K is naturally present in the diet and can also be taken as a supplement. As a nutrient class, it differs from herbs or botanical extracts: vitamin K is not a plant extract with multiple phytochemicals but a defined group of vitamins critical for specific biochemical reactions. While intestinal bacteria produce some menaquinones, the amount is variable and often insufficient on its own, making dietary intake important.

Benefits of Vitamin K

Supports normal blood clotting: Strong evidence shows vitamin K is required to activate key clotting factors. Adequate intake helps maintain normal coagulation and reduces the risk of excessive bleeding due to deficiency. This is a fundamental, well-established role.
Bone health and calcium balance: Moderate evidence suggests vitamin K helps activate osteocalcin, a protein that binds calcium in bone. Some trials report improved bone mineral density or reduced fracture risk, especially with K2 forms, but findings are mixed and not universally consistent.
Vascular calcification regulation: Limited to moderate evidence indicates vitamin K–dependent proteins (like MGP) help inhibit calcium buildup in arteries. Observational studies link higher K intake with less calcification, but randomized trial results are mixed and still emerging.
Potential synergy with vitamin D: Preliminary to moderate evidence supports a complementary role with vitamin D in bone health. Together, they may improve markers of bone turnover, though definitive fracture reduction data for the combo remain limited.
Newborn bleeding prevention: Strong evidence supports vitamin K administration at birth to prevent vitamin K deficiency bleeding (VKDB) in infants. This is standard medical practice, typically via injection.
Potential metabolic and cognitive effects: Early research suggests possible benefits for insulin sensitivity and cognitive aging biomarkers, particularly with K2 (MK-7), but current data are limited and not conclusive.

Evidence Summary

Strong evidence: Essential role in coagulation; prevention and treatment of vitamin K deficiency bleeding, especially in newborns; correction of deficiency-related prolonged clotting times.
Moderate evidence: Contribution to bone health via osteocalcin activation; some RCTs show benefits (more often with MK-7 or high-dose MK-4 in specific settings), but results are not uniform.
Limited or mixed evidence: Reduction of arterial stiffness and vascular calcification; synergistic effects with vitamin D on clinically meaningful outcomes; effects on glucose metabolism or cognition.
Overall: Well-established necessity for clotting; promising but mixed data for bone and cardiovascular outcomes. More high-quality, long-duration trials are needed to define who benefits most and optimal dosing by form.

Deficiency or Low Levels of Vitamin K

Common signs of low levels: Easy bruising, nosebleeds, bleeding gums, prolonged bleeding from cuts, heavy menstrual bleeding, blood in stool or urine, and in severe cases prolonged clotting times on lab tests. In infants, deficiency can cause dangerous internal bleeding, including intracranial hemorrhage.
Who may be at risk: Newborns (low stores at birth), individuals with fat malabsorption (e.g., celiac disease, cystic fibrosis, inflammatory bowel disease, chronic pancreatitis), people following very low-fat diets, those after bariatric surgery, long-term users of broad-spectrum antibiotics (which can reduce gut bacterial production of menaquinones), and people taking medications that impair fat absorption (e.g., orlistat, bile acid sequestrants). Older adults with low vegetable intake and individuals with liver disease may also be at higher risk.
How it is checked: Clinically, prolonged prothrombin time (PT)/INR can suggest vitamin K–related clotting issues. More specific markers include PIVKA-II (undercarboxylated prothrombin) and undercarboxylated osteocalcin, which reflect vitamin K status in clotting and bone, respectively. A healthcare professional interprets these tests in context with diet, medications, and health conditions.

Types or Forms Available

Vitamin K1 (phylloquinone): The primary dietary form from leafy greens and plant oils. Common in multivitamins and standalone supplements. Shorter half-life than some K2 forms but effective for supporting coagulation and overall vitamin K status.
Vitamin K2 (menaquinones): A family of forms designated MK-4, MK-7, etc. MK-7 (from natto fermentation) has a longer half-life and may sustain more stable blood levels with daily low doses; MK-4 is found in some animal foods and is also used in higher-dose supplements in certain countries for bone health. Evidence varies by subtype.
MK-7: Often supplied at 90–200 micrograms per day in supplements. Its longer half-life may enhance carboxylation of vitamin K–dependent proteins with once-daily dosing.
MK-4: Present in some foods and available as supplements. Clinical studies have used a wide range of doses; high pharmacological doses (e.g., 45 mg/day) used in parts of Asia for osteoporosis require medical oversight and are not typical over-the-counter strategies elsewhere.
Menadione (K3): A synthetic form not recommended for human supplementation due to safety concerns. It is not used in reputable consumer products.
Formulations and delivery: Softgels in oil, tablets, and drops are common. Because vitamin K is fat-soluble, oil-based forms and taking with a meal containing fat can improve absorption. Some products combine vitamin K with vitamin D3 and calcium for bone-focused formulations.

How to Use Vitamin K

Most people can meet their needs through food. When supplements are considered, match the form and dose to your goals and medical context, especially if you take medications that affect clotting.

Common dosage range: For general nutritional support, typical supplemental doses are about 50–120 micrograms/day of K1 or 90–200 micrograms/day of MK-7. Intakes around the Adequate Intake (AI) level—about 120 micrograms/day for adult men and 90 micrograms/day for adult women—are commonly used from diet plus supplements. High-dose MK-4 regimens should only be used under medical supervision.
Best timing: Take with a meal that contains fat to enhance absorption. Once-daily dosing is usually sufficient; MK-7’s longer half-life supports steady levels with daily use.
How to take it: Swallow softgels or tablets with water and a fat-containing meal (e.g., eggs, avocado, olive oil). Liquid drops should also be taken with food unless otherwise directed.
Consistency: Daily, consistent intake is important. If you use warfarin (a vitamin K antagonist), do not start or stop supplements or drastically change your intake of vitamin K–rich foods without medical guidance; consistency is critical for stable INR.

Food Sources and Supplement Options

Vitamin K is widely available in foods and as supplements. K1 is abundant in green leafy vegetables and certain plant oils, while K2 is found in fermented foods and some animal products. Whole foods provide vitamin K alongside fiber, minerals, and phytonutrients, whereas supplements offer targeted, predictable doses that can help when intake is low or when specific forms (e.g., MK-7) are desired.

Leafy greens: kale, spinach, collards, Swiss chard, mustard greens, beet greens.
Cruciferous vegetables: broccoli, Brussels sprouts, cabbage.
Herbs and others: parsley, cilantro, green lettuce varieties.
Plant oils: soybean, canola, and olive oil (K1 content varies).
Fermented foods: natto (very high in MK-7), some aged cheeses (e.g., Gouda, Edam) with varying K2 content.
Animal foods: egg yolks, liver, dark poultry meat, and some dairy, contributing K2 (often MK-4 in small amounts).

Supplementation may make sense for people with low vegetable intake, those with malabsorption issues, or individuals who wish to target bone health markers with a consistent K2 (MK-7) dose. For many, a food-first approach works well; however, supplements can help ensure adequacy and consistency, particularly when diet is variable. Discuss supplementation with a healthcare professional if you are pregnant, breastfeeding, taking medications, or managing a medical condition.

Who May Benefit from Vitamin K?

Individuals with low intake of green vegetables or fermented foods who may not meet daily needs through diet alone.
Older adults concerned about bone health, particularly those with osteopenia/osteoporosis risk, recognizing that evidence for fracture reduction is mixed and should complement, not replace, broader bone-health strategies.
People with fat malabsorption (e.g., celiac disease, cystic fibrosis, inflammatory bowel disease) or those after bariatric surgery, as they may require careful monitoring and guided supplementation.
Individuals on long-term broad-spectrum antibiotics, which can reduce gut-derived K2 production; short-term supplementation may be considered under guidance.
Athletes with restrictive diets or low energy availability who struggle to meet micronutrient needs; dietitians often prioritize a food-first plan with targeted supplementation as needed.
People aiming for consistent vitamin K intake while on warfarin, but only under medical supervision to maintain a stable INR; supplementation should not be self-initiated.

Side Effects and Considerations

Medication interactions: Vitamin K directly opposes the effect of warfarin and other vitamin K antagonists. Do not start, stop, or change your vitamin K intake (foods or supplements) without clinician guidance if you use these medications. Direct oral anticoagulants (DOACs) are generally not affected by vitamin K, but consult your prescriber.
Bleeding/thrombosis risk management: Vitamin K itself does not “over-clot” blood in healthy individuals; it supports normal function. The main risk is altering anticoagulant control (e.g., INR changes) when intake changes unpredictably.
Gastrointestinal effects: Supplements are usually well tolerated. Mild GI upset can occur in some people, especially when taken on an empty stomach.
Allergies and sensitivities: Rare hypersensitivity reactions may occur. Review inactive ingredients (e.g., soy oil carriers) if you have allergies.
Absorption inhibitors: Drugs that reduce fat absorption (orlistat), bile acid sequestrants (cholestyramine, colesevelam), mineral oil, and chronic broad-spectrum antibiotics can lower vitamin K status. Your clinician may advise timing strategies or supplementation.
High-dose considerations: Pharmacological doses (e.g., high MK-4) should only be used with medical oversight. Do not self-prescribe megadoses.
Liver and biliary conditions: Cholestasis and other fat-absorption disorders reduce vitamin K uptake. Specialized forms or dosing may be required under clinical care.
Nutrient interactions: Very high doses of vitamin E may antagonize vitamin K–dependent clotting and increase bleeding risk, particularly in those on anticoagulants. Balance overall supplementation thoughtfully.
Pregnancy, breastfeeding, and children: Usual dietary intake is considered safe. Pregnant and breastfeeding individuals should consult a healthcare professional before using supplements. Newborns typically receive vitamin K at birth per medical guidelines; do not substitute over-the-counter products for infant care without medical advice.
Surgery: If you are scheduled for surgery and take anticoagulants, coordinate vitamin K intake with your healthcare team well in advance to maintain safe clotting control.
Product quality: Choose reputable brands with third-party testing. For K2 (MK-7), look for products specifying all-trans isomer content and stable formulations, as isomer profile can affect activity.

Common Myths About Vitamin K

Myth: “Vitamin K is just one vitamin.” In reality, vitamin K is a family of compounds. K1 (phylloquinone) predominates in plants, while K2 (menaquinones like MK-4 and MK-7) varies by source and behavior in the body. Forms differ in half-life, food sources, and potentially in clinical effects.
Myth: “If you take blood thinners, you must avoid leafy greens.” For people on warfarin, the goal is consistent vitamin K intake, not avoidance. Sudden changes in consumption can destabilize INR. Work with your healthcare team to set a steady dietary pattern; many can safely include leafy greens in a consistent manner.
Myth: “More vitamin K always means stronger bones.” While vitamin K supports osteocalcin activation, more is not always better. Evidence for fracture reduction is mixed, and high-dose regimens should not be used without medical guidance. Bone health is multifactorial: diet quality, vitamin D, calcium, protein, resistance training, and lifestyle all matter.
Myth: “Gut bacteria make all the vitamin K you need.” Although gut microbes produce some K2, amounts are variable and may not meet needs, especially during antibiotic use or in infants (who have low stores at birth). Dietary sources remain important.

Conclusion

Vitamin K is an essential, fat-soluble nutrient indispensable for normal blood clotting and involved in bone and vascular health through the activation of key proteins. Most people can meet their needs with a food-first approach that prioritizes leafy greens, cruciferous vegetables, plant oils, and, when desired, fermented foods like natto and certain cheeses. Supplements—particularly K1 or K2 (often MK-7)—can provide predictable intake when diets are inconsistent, when absorption is impaired, or when targeting bone-related biomarkers. Evidence for bone and cardiovascular outcomes is promising but mixed, so expectations should remain realistic.

If you are pregnant, breastfeeding, managing a medical condition, or taking medications—especially warfarin or other anticoagulants—consult a healthcare professional before using vitamin K supplements or making major dietary changes. Choose quality-tested products, take vitamin K with meals containing fat, and keep intake consistent. Used thoughtfully, vitamin K can support foundational aspects of health, with whole foods as the preferred starting point and supplements serving as targeted additions when appropriate.